Table 1.
Baseline demographics
| Variable | PPCPM(n = 259) | Usual care(n = 118) | P value |
|---|---|---|---|
| Age, mean (SD), y | 47.2 (10.5) | 50.4 (8.2) | .005 |
| Women, No. (%) | 155 (60) | 48 (41) | <.001 |
| Ethnicity, No. (%) | |||
| Black | 199 (77) | 98 (83) | .09 |
| White | 52 (20) | 13 (11) | |
| Hispanic | 5 (2) | 2 (2) | |
| Other/unknown | 3 (1.1) | 5 (3.3) | |
| BMI, mean (SD), mg/kg2 | 33.6 (8.3) | 31.6 (7.8) | .12 |
| Diabetes mellitus, No. (%) | 41 (16) | 30 (25) | .03 |
| Glycated hemoglobin, mean (SD), % | 8.0 (2.0) | 8.4 (2.3) | .219 |
| CAD, No. (%) | 7 | 22 | <.001 |
| eGFR (mL/min/1.73 m2), mean (SD) | 69.3 (21.1) | 91.6 (27.1) | <.001 |
| Current smoker, No. (%) | 107 (41) | 41 (34) | .18 |
| SBP, mean (SD), mm Hg | 158 (18.9) | 168.5 (26.6) | <.001 |
| DBP, mean (SD), mm Hg | 100.7 (12.1) | 98.6 (15.4) | .07 |
| Antihypertensive agents, mean (SD), No. | 0.67 (1.04) | 1.44 (1.41) | <.0001 |
| Antihypertensive agents, No. (%) | |||
| ACEI or ARB | 44 (17) | 48 (41) | <.001 |
| Thiazide diuretic | 44 (17) | 36 (30) | .004 |
| CCB | 36 (14) | 27 (23) | .027 |
| β‐Blocker | 25 (9) | 31 (26) | <.001 |
| Other | 18 (7) | 21 (18) | .002 |
Categorical variables were compared using chi‐square test; continuous variables were compared using nonparametric Wilcoxon‐Mann‐Whitney test.
Data sources: VCU Health System and Center for Healthy Hearts.
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blocker; CKD, chronic kidney disease; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; PPCPM, pharmacist‐physician collaborative practice model; SBP, systolic blood pressure; SD, standard deviation.